Relay Therapeutics paid its 5 named executives $11.0M in total in FY2025 (Dec). CEO Sanjiv K. Patel, M.D. was paid $4.6M of that.
Pay$100 in the stock at the end of FY20 → $20
Pay of each named executive
Sanjiv K. Patel, M.D.President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Donald Bergstrom, M.D., Ph.D.President, Research & Development
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Thomas CatinazzoChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Peter RahmerChief Corporate Development Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Brian R. AdamsFormer Chief Legal Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 12 peers with pay on file was $7.1M. The CEO of Relay Therapeutics was paid $4.6M, 35% below the median.
- 1Cogent Biosciences
- 2BridgeBio Pharma
- 3Arcus Biosciences
- 4Kymera Therapeutics
- 5Vir Biotechnology
- 6CRISPR Therapeutics AG
- 7Arvinas
- 8Beam Therapeutics
- 9Intellia Therapeutics
- 10Denali Therapeutics
- 11Relay TherapeuticsThis company
- 12Schrodinger
- 13Tango Therapeutics
- 14Alector, Inc.Not disclosed
- 15Allogene Therapeutics, Inc.Not disclosed
- 16Editas Medicine, Inc.Not disclosed
- 17ErascaNot disclosed
- 18IGM Biosciences, Inc.Not disclosed
- 19Iovance BiotherapeuticsNot disclosed
- 20Recursion PharmaceuticalsNot disclosed
- 21Sana BiotechnologyNot disclosed
- 22SpringWorks Therapeutics, Inc.Not disclosed
- 23Zentalis Pharmaceuticals, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.